Integrated Filing — IndAS


General information about company

Scrip Code 540935
NSE Symbol GALAXYSURF
MSEI Symbol NOTLISTED
ISIN INE600K01018
Name of company GALAXY SURFACTANTS LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-Apr-2024
Date of end of financial year 31-Mar-2025
Date of board meeting when results were approved 16-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 09-May-2025
Description of presentation currency INR (in Actuals)
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Single segment
Description of single segment Manufacturing of Chemicals
Start date and time of board meeting 16-May-2025   14:00:00
End date and time of board meeting 16-May-2025   18:15:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 2022-05-17
Indicate Company website link for updated RPT policy of the Company https://www.galaxysurfactants.com/pdf/corporate-governance/policies/Policy-on-Related-Party-Transactions.pdf
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
Not applicable



Financial Results Ind-AS

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Unaudited Audited
D Nature of report standalone or consolidated Standalone Standalone
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Income
Revenue from operations 8142500000 30012700000
Other income 66900000 264500000
Total income 8209400000 30277200000
2 Expenses
(a) Cost of materials consumed 6185900000 21888500000
(b) Purchases of stock-in-trade 25800000 211300000
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade -130200000 -398000000
(d) Employee benefit expense 405900000 1710800000
(e) Finance costs 53400000 165900000
(f) Depreciation, depletion and amortisation expense 170600000 671800000
(f) Other Expenses
1 Other Expenses 904800000 3779200000
Total other expenses 904800000 3779200000
Total expenses 7616200000 28029500000
3 Total profit before exceptional items and tax 593200000 2247700000
4 Exceptional items 0 0
5 Total profit before tax 593200000 2247700000
6 Tax expense
7 Current tax 122700000 511600000
8 Deferred tax 30100000 -2100000
9 Total tax expenses 152800000 509500000
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0 0
11 Net Profit Loss for the period from continuing operations 440400000 1738200000
12 Profit (loss) from discontinued operations before tax 0 0
13 Tax expense of discontinued operations 0 0
14 Net profit (loss) from discontinued operation after tax 0 0
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0 0
16 Total profit (loss) for period 440400000 1738200000
17 Other comprehensive income net of taxes -33600000 -27900000
18 Total Comprehensive Income for the period 406800000 1710300000
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 354500000 354500000
Face value of equity share capital 10 10
27 Details of debt securities
22 Reserves excluding revaluation reserve 13992800000
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 12.42 49.03
Diluted earnings (loss) per share from continuing operations 12.42 49.03
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 12.42 49.03
Diluted earnings (loss) per share from continuing and discontinued operations 12.42 49.03
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2024
Date of end of reporting period 31-Mar-2025
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 6989100000
Capital work-in-progress 2538800000
Investment property 0
Goodwill 0
Other intangible assets 31200000
Intangible assets under development 0
Biological assets other than bearer plants 0
Investments accounted for using equity method 0
Non-current financial assets
Non-current investments 1177900000
Trade receivables, non-current 0
Loans, non-current 17800000
Other non-current financial assets 185700000
Total non-current financial assets 1381400000
Deferred tax assets (net) 0
Other non-current assets 290700000
Total non-current assets 11231200000
2 Current assets
Inventories 4375900000
Current financial asset
Current investments 955200000
Trade receivables, current 4928100000
Cash and cash equivalents 89500000
Bank balance other than cash and cash equivalents 138800000
Loans, current 8700000
Other current financial assets 111400000
Total current financial assets 6231700000
Current tax assets (net) 82200000
Other current assets 1326600000
Total current assets 12016400000
3 Non-current assets classified as held for sale 0
4 Regulatory deferral account debit balances and related deferred tax Assets 0
Total assets 23247600000
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 354500000
Other equity 13992800000
Total equity attributable to owners of parent 14347300000
Non controlling interest
Total equity 14347300000
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 171300000
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0
Total Trade payable 0
Other non-current financial liabilities 190800000
Total non-current financial liabilities 362100000
Provisions, non-current 100100000
Deferred tax liabilities (net) 341800000
Deferred government grants, Non-current 31500000
Other non-current liabilities 0
Total non-current liabilities 835500000
Current liabilities
Current financial liabilities
Borrowings, current 1197800000
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 89000000
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 5035400000
Total Trade payable 5124400000
Other current financial liabilities 264500000
Total current financial liabilities 6586700000
Other current liabilities 1376800000
Provisions, current 64800000
Current tax liabilities (Net) 35300000
Deferred government grants, Current 1200000
Total current liabilities 8064800000
3 Liabilities directly associated with assets in disposal group classified as held for sale 0
4 Regulatory deferral account credit balances and related deferred tax liability 0
Total liabilities 8900300000
Total equity and liabilites 23247600000
Disclosure of notes on assets and liabilities



Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Jan-2025 01-Apr-2024
Date of end of reporting period 31-Mar-2025 31-Mar-2025
Whether accounts are audited or unaudited Unaudited Audited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Unaudited Audited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Items that will not be reclassified subsequently to profit or loss -44800000 -37300000
Total Amount of items that will not be reclassified to profit and loss -44800000 -37300000
2 Income tax relating to items that will not be reclassified to profit or loss -11200000 -9400000
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss
5 Total Other comprehensive income -33600000 -27900000



Cash flow statement, indirect

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 2024-04-01
B Date of end of reporting period 2025-03-31
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Standalone
Part I Blue color marked fields are non-mandatory.
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 2247700000
Adjustments for reconcile profit (loss)
Adjustments for finance costs 165900000
Adjustments for decrease (increase) in inventories -1099500000
Adjustments for decrease (increase) in trade receivables, current -964300000
Adjustments for decrease (increase) in trade receivables, non-current 0
Adjustments for decrease (increase) in other current assets 0
Adjustments for decrease (increase) in other non-current assets 0
Adjustments for other financial assets, non-current 0
Adjustments for other financial assets, current 0
Adjustments for other bank balances 0
Adjustments for increase (decrease) in trade payables, current 2659700000
Adjustments for increase (decrease) in trade payables, non-current 0
Adjustments for increase (decrease) in other current liabilities 0
Adjustments for increase (decrease) in other non-current liabilities 0
Adjustments for depreciation and amortisation expense 671800000
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss -100000
Adjustments for provisions, current 0
Adjustments for provisions, non-current 0
Adjustments for other financial liabilities, current 0
Adjustments for other financial liabilities, non-current 0
Adjustments for unrealised foreign exchange losses gains -5300000
Adjustments for dividend income 0
Adjustments for interest income 33500000
Adjustments for share-based payments 0
Adjustments for fair value losses (gains) -229200000
Adjustments for undistributed profits of associates 0
Other adjustments for which cash effects are investing or financing cash flow 4800000
Other adjustments to reconcile profit (loss) 0
Other adjustments for non-cash items 4400000
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0
Total adjustments for reconcile profit (loss) 1174700000
Net cash flows from (used in) operations 3422400000
Dividends received 0
Interest paid 0
Interest received 0
Income taxes paid (refund) 467800000
Other inflows (outflows) of cash 0
Net cash flows from (used in) operating activities 2954600000
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0
Cash flows used in obtaining control of subsidiaries or other businesses 135700000
Other cash receipts from sales of equity or debt instruments of other entities 0
Other cash payments to acquire equity or debt instruments of other entities 649200000
Other cash receipts from sales of interests in joint ventures 0
Other cash payments to acquire interests in joint ventures 0
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0
Proceeds from sales of property, plant and equipment 22900000
Purchase of property, plant and equipment 2000200000
Proceeds from sales of investment property 0
Purchase of investment property 0
Proceeds from sales of intangible assets 0
Purchase of intangible assets 0
Proceeds from sales of intangible assets under development 0
Purchase of intangible assets under development 0
Proceeds from sales of goodwill 0
Purchase of goodwill 0
Proceeds from biological assets other than bearer plants 0
Purchase of biological assets other than bearer plants 0
Proceeds from government grants 0
Proceeds from sales of other long-term assets 0
Purchase of other long-term assets 0
Cash advances and loans made to other parties 0
Cash receipts from repayment of advances and loans made to other parties 0
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0
Dividends received 0
Interest received 32800000
Income taxes paid (refund) 0
Other inflows (outflows) of cash 1081300000
Net cash flows from (used in) investing activities -1648100000
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0
Payments from changes in ownership interests in subsidiaries 0
Proceeds from issuing shares 0
Proceeds from issuing other equity instruments 0
Payments to acquire or redeem entity's shares 0
Payments of other equity instruments 0
Proceeds from exercise of stock options 0
Proceeds from issuing debentures notes bonds etc 0
Proceeds from borrowings 0
Repayments of borrowings -158100000
Payments of lease liabilities 61600000
Dividends paid 1350900000
Interest paid 182000000
Income taxes paid (refund) 0
Other inflows (outflows) of cash 0
Net cash flows from (used in) financing activities -1436400000
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes -129900000
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 400000
Net increase (decrease) in cash and cash equivalents -129500000
Cash and cash equivalents cash flow statement at beginning of period 219000000
Cash and cash equivalents cash flow statement at end of period 89500000







Details of Impact of Audit Qualification

Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 Deloitte Haskins & Sells LLP Yes 31-Jul-2027


Financial details

Sr. Particulars Audited Figures (as reported before adjusting for qualifications) Adjusted Figures (audited figures after adjusting for qualifications)
1 Turnover / Total income
2 Total Expenditure
3 Net Profit/(Loss)
4 Earnings Per Share
5 Total Assets
6 Total Liabilities
7 Net Worth




Signatories detail

Name of CEO / Managing director
Name of CFO
Name of audit committee chairman
Name of statutory auditor
Name of other signatory, if any, with designation
Place
Date



Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)

Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity /subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 Galaxy Surfactants Limited Galaxy Chemicals (Egypt) S.A.E. Subsidiary Sale of goods or services Nil 2164100000 208900000 229000000
2 Galaxy Surfactants Limited Galaxy Chemicals (Egypt) S.A.E. Subsidiary Purchase of goods or services Nil 96800000 35500000 5500000
3 Galaxy Surfactants Limited Galaxy Chemicals (Egypt) S.A.E. Subsidiary Any other transaction Corporate Guarantee Commission income Nil 200000 200000 0
4 Galaxy Surfactants Limited Galaxy Chemicals (Egypt) S.A.E. Subsidiary Any other transaction Reimburesement expenses Nil 1200000 6500000 700000
5 Galaxy Chemicals (Egypt) S.A.E. Galaxy Surfactants Limited Holding Company Any other transaction Reimburesement expenses Nil 0 500000 0
6 Galaxy Surfactants Limited TRI-K Industries Inc. Subsidiary Sale of goods or services Nil 2039300000 228400000 11300000
7 Galaxy Surfactants Limited TRI-K Industries Inc. Subsidiary Purchase of goods or services Nil 55700000 11100000 8700000
8 Galaxy Surfactants Limited TRI-K Industries Inc. Subsidiary Any other transaction Reimburesement expenses Nil 3900000 3800000 3900000
9 Galaxy Surfactants Limited TRI-K Industries Inc. Subsidiary Any other transaction Shared Services Nil 5000000 4000000 5000000
10 TRI-K Industries Inc. Galaxy Surfactants Limited Holding Company Any other transaction Reimburesement expenses Nil 800000 500000 800000
11 Galaxy Surfactants Limited Galaxy Surfactants Americas Subsidiary Sale of goods or services Nil 237200000 0 150100000
12 Galaxy Surfactants Limited Galaxy Holdings (Mauritius) Ltd Subsidiary Investment Nil 1081100000 1955000000 1037600000
13 Galaxy Surfactants Limited G.Ramakrishnan Related Party Any other transaction Consultancy Fees Nil 9000000 0 800000
14 Galaxy Surfactants Limited Uday Kamat Related Party Any other transaction Consultancy Fees Nil 9000000 0 800000
15 Galaxy Surfactants Limited Galaxy Surfactants Americas Subsidiary Any other transaction Reimburesement expenses Nil 1400000 0 1400000
16 Galaxy Surfactants Limited Galaxy Surfactants Americas Subsidiary Investment Nil 0 1500000 4600000
17 Galaxy Surfactants Limited Galaxy Surfactants Mexico SA DE CV Subsidiary Investment Nil 83400000 0 83400000
18 Galaxy Surfactants Limited Tri-K Mexico SA DE CV Subsidiary Investment Nil 43000000 0 43000000
19 Galaxy Surfactants Limited Galaxy Specialties Europe BV Subsidiary Investment Nil 9300000 0 9300000
20 Galaxy Surfactants Limited Galaxy Surfactants Mexico SA DE CV Subsidiary Any other transaction Reimburesement expenses Nil 1300000 0 1300000
21 Galaxy Surfactants Limited Tri-K Mexico SA DE CV Subsidiary Any other transaction Reimburesement expenses Nil 700000 0 700000
22 Galaxy Surfactants Limited Galaxy Specialties Europe BV Subsidiary Any other transaction Reimburesement expenses Nil 300000 0 300000
Total value of transaction during the reporting period 5842700000





Format for Disclosing Outstanding Default on Loans and Debt Securities

Sr. No. Particulars Amount Remarks
1. Loans / revolving facilities like cash credit from banks / financial institutions
A Total amount outstanding as on date
B Of the total amount outstanding, amount of default as on date
2. Unlisted debt securities i.e. NCDs and NCRPS
A Total amount outstanding as on date
B Of the total amount outstanding, amount of default as on date
3. Total financial indebtedness of the listed entity including short-term and long-term debt